SJM
29
-2
SIG
47
-3
LYB
32
2
MMM
30
2
AMGN
47
-13
HCA
55
2
AKAM
48
-11
WRK
60
-3
GOOGL
67
3
OMC
53
3
AIV
60
3
BAC
44
-4
HAS
49
3
CAG
39
5
GM
61
-4
SO
70
-3
VFC
45
3
CA
40
4
MU
43
-4
UNP
50
4
SJM
29
-2
SIG
47
-3
LYB
32
2
MMM
30
2
AMGN
47
-13
HCA
55
2
AKAM
48
-11
WRK
60
-3
GOOGL
67
3
OMC
53
3
AIV
60
3
BAC
44
-4
HAS
49
3
CAG
39
5
GM
61
-4
SO
70
-3
VFC
45
3
CA
40
4
MU
43
-4
UNP
50
4
Financhill
Back

MercadoLibre Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
56

MELI
MercadoLibre

Last Price:
1,600.88
Seasonality Move:
12.97%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Buy
56
MercadoLibre (MELI) is a Buy

Is MercadoLibre a Buy, Sell or Hold?

  • The current MercadoLibre [MELI] share price is $1,599.95. The Score for MELI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • MELI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MELI Stock Price Chart

What is MercadoLibre's stock price today?

  • The MercadoLibre share price today is $1,599.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MELI is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

MELI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -15.6 Sell
Relative Strength Index (14 RSI): 46.73 Sell
Chaikin Money Flow: -10484 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1586.56 - 1728.44) Sell
Bollinger Bands (100): (1478.94 - 1715.42) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

MELI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1582.21 Buy
20-day SMA: 1632.62 Sell
50-day SMA: 1584.99 Buy
200-day SMA: 1523.27 Buy
8-day EMA: 1590.87 Buy
20-day EMA: 1614.1 Sell
50-day EMA: 1607.52 Sell
200-day EMA: 1514.74 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

MercadoLibre Earnings Growth & MELI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $3.78 per share, an increase next quarter of $2.22 per share, an increase this year of $10.83 per share, and an increase next year of $11.13 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

MercadoLibre Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):